100+ Vk2809 10 mg qod PowerPoint (PPT) Presentations, Vk2809 10 mg qod PPTs

Vk2809 10 mg qod - PowerPoint PPT Presentation

VK2809 in NAFLD: a phase 2 study

VK2809 in NAFLD: a phase 2 study. Design. Follow-up. Placebo (N = 15). NAFLD patients with LDL-C > 110 mg/dL Liver fat content > 8% (MRI-PDFF). 10 mg VK2809 QOD (N = 16). Randomization. 10 mg VK2809 QD (N = 16). Double-Blind Treatment. Screening MRI-PDFF. D 1. W 1. W 4. W 6. W 8.

★ ★ ★ ★ ★

235 views • 7 slides

View Vk2809 10 mg qod PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Vk2809 10 mg qod PowerPoint presentations. You can view or download Vk2809 10 mg qod presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.

'Vk2809 10 mg qod' presentation slideshows

Vk2809 10 mg qod - PowerPoint PPT Presentation

VK2809 in NAFLD: a phase 2 study